Loading...
Relief Therapeutics Holding AG
RLF.SW•SIX
Healthcare
Biotechnology
CHF2.88
CHF0.02(0.87%)
Swiss Market is Open • 10:06Relief Therapeutics Holding AG (RLF.SW) AI-Powered Stock Analysis
See how Relief Therapeutics Holding AG scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerRelief Therapeutics Holding AG (RLF.SW) Stock Overall Grade
Relief Therapeutics Holding AG’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Relief Therapeutics Holding AG's overall stock rating.
Forecast
C+Score
55/100Financial Growth
BScore
65/100Fundamental Growth
DScore
33/100Key Ratios
C+Score
55/100Sector Comparison
A+Score
100/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
95/100Analyst Consensus
C+Score
50/100Relief Therapeutics Holding AG (RLF.SW) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 55/100 (C+), reflecting weak confidence in its potential. Financial Growth (65/100, B) and Fundamental Growth (33/100, D) highlight its stability, while Key Ratios (55/100, C+) and Sector Comparison (100/100, A+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (95/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Relief Therapeutics Holding AG stock grade, including financials, comparisons, and forecasts.